Europe does not lack health innovation.

It lacks distribution.

That is the argument in tomorrow’s HealthVC newsletter.

European healthtech companies often have strong science, serious founders, respected clinical relationships, and real patient need.

But turning that into a global category leader is a very different challenge.

The product can work.

The company still has to move.